1-phthalidyl-5-fluorouracil has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Kimura, K; Okamoto, M; Takao, A | 1 |
| Furue, H | 1 |
2 other study(ies) available for 1-phthalidyl-5-fluorouracil and Experimental Hepatoma
| Article | Year |
|---|---|
[Pharmacokinetics of 1-phthalidyl-5-fluorouracil (PH-FU)].
Topics: Administration, Oral; Animals; Biological Assay; Fluorouracil; Kinetics; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Rabbits; Sarcoma, Yoshida | 1986 |
[590-S].
Topics: Administration, Oral; Adult; Animals; Anorexia; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Leukemia, Experimental; Liver Neoplasms, Experimental; Male; Mice; Middle Aged; Nausea; Neoplasms, Experimental; Rabbits; Rats; Sarcoma, Experimental; Stomach Neoplasms | 1985 |